Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | fatty acid synthase | 0.0024 | 0.4143 | 0.4558 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0024 | 0.4032 | 0.5436 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0026 | 0.463 | 0.481 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0024 | 0.4032 | 0.5436 |
Mycobacterium ulcerans | polyketide synthase | 0.0025 | 0.4229 | 0.4065 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0023 | 0.3806 | 0.4147 |
Brugia malayi | hypothetical protein | 0.0018 | 0.2362 | 0.2043 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0037 | 0.7417 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.4875 | 0.545 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0025 | 0.4229 | 0.5702 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0037 | 0.7417 | 1 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0026 | 0.463 | 0.481 |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.4875 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0018 | 0.2414 | 0.3255 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0025 | 0.4229 | 0.4065 |
Brugia malayi | hypothetical protein | 0.0027 | 0.4875 | 0.4661 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0023 | 0.3806 | 0.5131 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0025 | 0.4229 | 0.4065 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0012 | 0.0965 | 1 |
Onchocerca volvulus | 0.0043 | 0.9002 | 0.9555 | |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0016 | 0.1965 | 0.241 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0025 | 0.4229 | 0.3988 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.001 | 0.0391 | 0.0527 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0026 | 0.463 | 0.9359 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0026 | 0.463 | 0.6242 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.1395 | 0.1211 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.3806 | 0.3547 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.4875 | 0.5 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0026 | 0.463 | 0.481 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.8611 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.002 | 0.297 | 0.172 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.4875 | 0.5 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0037 | 0.7417 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0025 | 0.4229 | 0.4065 |
Mycobacterium ulcerans | polyketide synthase | 0.0026 | 0.463 | 0.481 |
Mycobacterium ulcerans | thioesterase TesA | 0.0021 | 0.3155 | 0.2064 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0021 | 0.3155 | 0.2064 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0018 | 0.2372 | 0.3471 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0965 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.002 | 0.297 | 0.172 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0045 | 0.9402 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0025 | 0.4229 | 0.4065 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.4875 | 0.5 |
Loa Loa (eye worm) | acyl carrier protein | 0.0011 | 0.0748 | 0.0423 |
Onchocerca volvulus | 0.0023 | 0.3806 | 0.3783 | |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0037 | 0.7417 | 1 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0021 | 0.3155 | 0.4254 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.4875 | 0.5 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0025 | 0.4229 | 0.4065 |
Mycobacterium ulcerans | thioesterase | 0.0021 | 0.3155 | 0.2064 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0026 | 0.463 | 0.6242 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0025 | 0.4229 | 0.5702 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0026 | 0.463 | 0.481 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.4875 | 0.5 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0012 | 0.0965 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.002 | 0.297 | 0.172 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.4875 | 0.5 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0026 | 0.463 | 0.6242 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.002 | 0.3055 | 0.4119 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0025 | 0.4229 | 0.4065 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.4875 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0014 | 0.1448 | 0.1953 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0026 | 0.463 | 0.481 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0025 | 0.4229 | 0.5702 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.